- recruitingTherapeutic confirmatory (Phase III)
A Greek multicenter, single-arm, low-intervention clinical trial to evaluate the efficacy and safety of irbesartan/amlodipine fixed combination in newly diagnosed patients or patients with uncontrolled arterial hypertension.
This clinical trial looks at a combined tablet containing two blood pressure medicines (irbesartan and amlodipine). Researchers want to see how safely and effectively this single daily pill lowers blood pressure over 16 weeks in adults who are newly diagnosed or whose current treatment is not working well enough.
Greece - recruitingPhase III and phase IV (Integrated)
Effects of single-pill combination of telmisartan/amlodipine and telmisartan/amlodipine/hydrochlorothiazide on 24-hour blood pressure (BP) reduction, 24-h BP variability and office BP control in patients with arterial hypertension – SATELLITE
This study looks at how new combination medicines affect high blood pressure over 24 hours. Researchers want to see how well these pills lower blood pressure and keep it steady throughout the day in people with high blood pressure.
Slovenia · Hungary · Poland - recruiting
Global Research Initiative for Patients Screening on MASH
This study aims to improve how doctors find serious liver conditions like MASH in people with health problems like diabetes or obesity. It brings together healthcare providers across Europe to use new care guidelines and raise awareness about these liver diseases.
Belgium · Czechia · France